REVIEW PAPER
HIV retesting among pregnant women: a literature review
More details
Hide details
1
Faculty of Health Sciences, Universitas ‘Aisyiyah Yogyakarta, Yogyakarta, Indonesia
2
Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
3
Centre for Bio and Medical Humanities, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
4
Department of Public Health, School of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
5
Department of Anthropology, Faculty of Cultural Sciences, Universitas Gadjah Mada, Indonesia
Submission date: 2022-07-07
Final revision date: 2022-08-30
Acceptance date: 2022-08-30
Online publication date: 2025-05-05
Corresponding author
Dhesi Ari Astuti
Faculty of Health Sciences, Universitas ‘Aisyiyah Yogyakarta,
Yogyakarta, Indonesia
HIV & AIDS Review 2025;24(2):100-106
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Human immunodeficiency virus (HIV) occurrence in pregnancy remains high, with
11 in 1,087 women infected during pregnancy, resulting in 1% of seroconversion risk and HIV incidence rate of 4 per 100 pregnant women annually. In addition, sexual activities in the first trimester of pregnancy are more frequent than in the third trimester and during postpartum. The aim of this review was to investigate HIV retesting among pregnant women, and influential factors of HIV testing.
Material and Methods:
This study employed a search through three databases, such as Wiley, ProQuest, and PubMed. Articles selected for analysis were published between 2010 and 2020, written English, and were primary articles. Critical appraisal stage used a checklist from the Joanna Briggs Institute.
Results:
There were 8 articles selected from Africa and America. Research designs included cohort studies, qualitative papers, and randomized controlled trials. HIV retesting for pregnant women was found cost-saving, beneficial for their future health, and economically and emotionally advantageous, while disadvantage was an extra cost in areas with low HIV prevalence. The influential factors were the government policy, antenatal care, and HIV-integrated services as well as the role of healthcare providers.
HIV test can generally be performed in the third trimester or 3 months after the first test.
Conclusions:
HIV retesting among pregnant women is crucial for the health of the mother, child, and family. It is highly associated with false HIV-negative status, which can be otherwise positive due to getting infected during pregnancy.
REFERENCES (41)
2.
UNAIDS. Progress report on the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. Joint United Nations Programme on HIV/AIDS (UNAIDS), 2015. Available at:
http://www.unaids.org/sites/de... (Accessed: 06.02.2025).
4.
Muhaimin T. Prevalensi HIV pada ibu hamil di delapan ibu kota provinsi di Indonesia tahun 2003-2010. Makara Journal of Health Research 2011; 15. DOI:
https://doi.org/10.7454/msk.v1....
6.
Byamugisha R, Tumwine JK, Ndeezi G, Karamagi CAS, Tylleskär T. Attitudes to routine HIV counselling and testing, and knowledge about prevention of mother to child transmission of HIV in eastern Uganda: A cross-sectional survey among antenatal attendees. J Int AIDS Soc 2010; 13. DOI: 10.1186/1758-2652-13-52.
7.
Mayaphi SH, Martin DJ, Quinn TC, Stoltz AC. Vertical transmission of HIV among pregnant women who initially had false-negative rapid HIV tests in four South African antenatal clinics. PLoS One 2019; 14: e0226391. DOI: 10.1371/journal.pone.0226391.
8.
Olowokere AE, Adelakun OA, Komolafe AO. Knowledge, perception, access and utilisation of HIV counselling and testing among pregnant women in rural communities of Osogbo town, Nigeria. Aust J Rural Health 2018; 26: 33-41.
9.
Wesolowski LG, Delaney KP, Lampe MA, Nesheim SR. False-positive human immunodeficiency virus enzyme immunoassay results in pregnant women. PLoS One 2011; 6: e16538. DOI: 10.1371/journal.pone.0016538.
10.
Keating MA, Hamela G, Miller WC, Moses A, Hoffman IF, Hosseinipour MC. High HIV incidence and sexual behavior change among pregnant women in lilongwe, malawi: Implications for the risk of HIV acquisition. PLoS One 2012; 7: e39109. DOI: 10.1371/journal.pone.0039109.
11.
Chetty T, Vandormael A, Thorne C, Coutsoudis A. Incident HIV during pregnancy and early postpartum period: a population-based cohort study in a rural area in KwaZulu-Natal, South Africa. BMC Pregnancy Childbirth 2017; 17: 248. DOI: 10.1186/s12884-017-1421-6.
12.
Remis RS, Merid MF, Palmer RW, Whittingham E, King SM, Danson NS, et al. High uptake of HIV testing in pregnant women in Ontario, Canada. PLoS One 2012; 7: e48077. DOI: 10.1371/journal.pone.0048077.
13.
Johansson KA, Pedersen KB, Andersson AK. HIV testing of pregnant women: an ethical analysis. Dev World Bioeth 2011; 11: 109-119.
14.
Olugbenga I, Taiwo O, Laverty M, Ngige E, Anyaike C, Bakare R, et al. Clinic-based evaluation study of the diagnostic accuracy of a dual rapid test for the screening of HIV and syphilis in pregnant women in Nigeria. PLoS One 2018; 13: e0198698. DOI: 10.1371/journal.pone.0198698.
15.
Boeras DI, Luisi N, Karita E, McKinney S, Sharkey T, Keeling M, et al. Indeterminate and discrepant rapid HIV test results in couples’ HIV testing and counselling centres in Africa. J Int AIDS Soc 2011; 14: 18. DOI: 10.1186/1758-2652-14-18.
16.
MacQueen KM, Chen M, Jolly D, Mueller MP, Okumu E, Eley NT, et al. HIV testing experience and risk behavior among sexually active black young adults: a CBPR-based study using respondent-driven sampling in Durham, North Carolina. Am J Community Psychol 2015; 55: 433-443.
17.
Fakoya I, Álvarez-Del Arco D, Monge S, Copas AJ, Gennotte AF, Volny-Anne A, et al. HIV testing history and access to treatment among migrants living with HIV in Europe. J Int AIDS Soc 2018; 21 Suppl 4: e25123. DOI: 10.1002/jia2.25123.
18.
Ng’ang’a A, Waruiru W, Ngare C, Ssempijja V, Gachuki T, Njoroge I, et al. The status of HIV testing and counseling in Kenya: results from a nationally representative population-based survey. J Acquir Immune Defic Syndr 2014; 66 Suppl 1: S27-S36. DOI: 10.1097/QAI.0000000000000102.
19.
Iwuji C, Chimukuche RS, Zuma T, Plazy M, Larmarange J, Orne-Gliemann J, et al. Test but not treat: community members’ experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa. PLoS One 2020; 15: e0239513. DOI: 10.1371/journal.pone.0239513.
20.
De Rossi N, Dattner N, Cavassini M, Peters S, Hugli O, Darling KEA. Patient and doctor perspectives on HIV screening in the emergency department: a prospective cross-sectional study. PLoS One 2017; e0180389. DOI: 10.1371/journal.pone.0180389.
21.
Clouse K, Pettifor A, Shearer K, Maskew M, Bassett J, Larson B, et al. Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa. Trop Med Int Health 2013; 18: 451-460.
22.
Yapa HM, Dhlomo-Mphatswe W, Moshabela M, De Neve JW, Herbst C, Jiamsakul A, et al. A continuous quality improvement intervention to improve antenatal HIV care testing in rural South Africa: evaluation of implementation in a real-world setting. Int J Health Policy Manag 2022; 11: 610-628.
23.
Kim LH, Cohan DL, Sparks TN, Pilliod RA, Arinaitwe E, Caughey AB. The cost-effectiveness of repeat HIV testing during pregnancy in a resource-limited setting. J Acquir Immune Defic Syndr 2013; 63: 195-200.
24.
Wulandari LPL, Lubis DSM, Widarini P, Widyanthini DN, Wirawan IMA, Wirawan DN. HIV testing uptake among pregnant women attending private midwife clinics: challenges of scaling up universal HIV testing at the private sectors in Indonesia. Int J Health Plann Manage 2019; 34: 1399-1407.
25.
Golden LM, Fairlie L, Might F, Mojela S, Motsamai D, Motshepe S, et al. HIV retesting in pregnant women in South Africa: Outcomes of a quality improvement project targeting health systems’ weaknesses. South Afr J HIV Med 2018; 19: 784. DOI: 10.4102/sajhivmed.
26.
Joseph RH, Musingila P, Miruka F, Wanjohi S, Dande C, Musee P, et al. Expanded eligibility for HIV testing increases HIV diagnoses – a cross-sectional study in seven health facilities in western Kenya. PLoS One 2019; 14: e0225877. DOI: 10.1371/journal.pone.0225877.
27.
Egbe TO, Tazinya RMA, Halle-Ekane GE, Egbe EN, Achidi EA. Estimating HIV incidence during pregnancy and knowledge of prevention of mother-to-child transmission with an ad hoc analysis of potential cofactors. J Pregnancy 2016; 2016: 7397695. DOI: 10.1155/2016/7397695.
28.
Criniti SM, Aaron E, Levine AB. Using the rapid HIV test to rescreen women in the third trimester of pregnancy. J Midwifery Womens Health 2009; 54: 492-496.
29.
Hamela G, Tembo T, Rosenberg NE, Hoffman I, Lee C, Hosseini-pour M. Womens experiences of HIV testing and counselling in the labour ward: a case of Bwaila hospital. Malawi Med J 2013: 25: 36-39.
31.
Kementerian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Nomor 4 Tahun 2019, Standar Teknis Pemenuhan Mutu Pelayanan Dasar pada Standar Pelayanan Minimal Bidang Kesehatan. 2019.
32.
Joshi S, Kulkarni V, Gangakhedkar R, Mahajan U, Sharma S, Shirole D, et al. Cost-effectiveness of a repeat HIV test in pregnancy in India. BMJ Open 2015; 5: e006718. DOI: 10.1136/bmjopen-2014-006718.
34.
Butler A, Hall H, Copnell B. A guide to writing a qualitative systematic review protocol to enhance evidence-based practice in nursing and health care. Worldviews Evid Based Nurs 2016; 13: 241-249.
35.
Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S. PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res 2014; 14: 579. DOI: 10.1186/s12913-014-0579-0.
36.
Rodriguez PJ, Roberts DA, Meisner J, Sharma M, Owiredu MN, Gomez B, et al. Cost-effectiveness of dual maternal HIV and syphilis testing strategies in high and low HIV prevalence countries: a modelling study. Lancet Glob Health 2021; 9: e61-e71. DOI: 10.1016/S2214-109X(20)30395-8.
37.
Wagner AD, Kinuthia J, Dettinger J, Mwongeli N, Gómez L, Watoyi S, et al. Challenges of discrepant HIV tests in pregnant women in the PrEP era – to treat or not to treat? J Infect Dis 2021; 223: 234-237.
38.
Kendall T. Consequences of missed opportunities for HIV testing during pregnancy and delayed diagnosis for mexican women, children and male partners. PLoS One 2014; 9: e109912. DOI: 10.1371/journal.pone.0109912.
39.
Gunn JK, Asaolu IO, Center KE, Gibson SJ, Wightman P, Ezeanolue EE, Ehiri JE. Antenatal care and uptake of HIV testing among pregnant women in sub-Saharan Africa: a cross-sectional study. J Int AIDS Soc 2016; 19: 20605. DOI: 10.7448/IAS.19.1.20605.
40.
Mugo PM, Wahome EW, Gichuru EN, Mwashigadi GM, Thiong'o AN, Prins HA et al. Effect of text message, phone call, and in-person appointment reminders on uptake of repeat HIV testing among outpatients screened for acute HIV infection in Kenya: a randomized controlled trial. PLoS One 2016; 11: e0153612. DOI: 10.1371/journal.pone.0153612.
41.
McAllister S, Lovell S, Dickson N. The impact of repeat testing in the Newzealand antenatal HIV screening programme: a qualitative study. J Med Screen 2013; 20: 1-6.